Histone deacetylase as a therapeutic target

OH Krämer, M Göttlicher, T Heinzel - Trends in Endocrinology & Metabolism, 2001 - cell.com
The maintenance of health depends on the coordinated and tightly regulated expression of
genetic information. Certain forms of leukemia have become paradigms for the pathogenic …

Histone deacetylase: a target for antiproliferative and antiprotozoal agents

PT Meinke, P Liberator - Current medicinal chemistry, 2001 - ingentaconnect.com
Histone deacetylase (HDAC) and histone acetyltransferase (HAT) are enzymes that
influence transcription by selectively deacetylating or acetylating the e-amino groups of …

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of …

AA Ruefli, MJ Ausserlechner… - Proceedings of the …, 2001 - National Acad Sciences
Many chemotherapeutic agents induce mitochondrial-membrane disruption to initiate
apoptosis. However, the upstream events leading to drug-induced mitochondrial …

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells

PN Munster, T Troso-Sandoval, N Rosen, R Rifkind… - Cancer research, 2001 - AACR
Histone deacetylase (HDACs) regulate histone acetylation by catalyzing the removal of
acetyl groups on the NH2-terminal lysine residues of the core nucleosomal histones …

DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors

WG Zhu, RR Lakshmanan, MD Beal, GA Otterson - Cancer research, 2001 - AACR
Histone acetylation has long been associated with transcriptional activation, whereas
conversely, deacetylation of histones is associated with gene silencing and transcriptional …

The Histone Deacetylase Inhibitor, CBHA, Inhibits Growth of Human Neuroblastoma Xenografts in Vivo, Alone and Synergistically with All-Trans Retinoic Acid

DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller… - Cancer research, 2001 - AACR
Histone deacetylase inhibitors (HDACIs) inhibit the growth of a variety of transformed cells in
culture. We demonstrated previously that the hybrid-polar HDACI m-carboxycinnamic acid …

Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase

LM Butler, Y Webb, DB Agus, B Higgins… - Clinical cancer …, 2001 - AACR
Purpose: We have synthesized a series of hybrid polar compounds that induce
differentiation and/or apoptosis of various transformed cells. These agents are also potent …

Up-regulation of p21WAF1/CIP1 by histone deacetylase inhibitors reduces their cytotoxicity

AJ Burgess, S Pavey, R Warrener, LJK Hunter… - Molecular …, 2001 - ASPET
Histone deacetylase inhibitors show promise as chemotherapeutic agents and have been
demonstrated to block proliferation in a wide range of tumor cell lines. Much of this …

Histone deacetylase inhibitors induce caspase‐dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17)

HM Amin, S Saeed, S Alkan - British journal of haematology, 2001 - Wiley Online Library
Histone deacetylase (HDAC) appears to play an important role in the pathogenesis of acute
promyelocytic leukaemia (APL) as it is recruited by both PML–RARα and PLZF/RARα in …

Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

VM Richon, X Zhou, RA Rifkind, PA Marks - Blood Cells, Molecules, and …, 2001 - Elsevier
Transformed cells have escaped normal growth regulatory signals and may be blocked at
discrete states of differentiation prior to the stage of terminal cell division and/or apoptosis …